Experimental hepatitis B drug might offer ‘functional cure’ for a subset of patients
In two international studies, about 1 in 5 patients given the experimental drug saw their virus reduced to levels low enough for the immune system to keep in check.
- Hepatitis B drug may offer 'functional cure' for some patients PBS —
- New drug can cure previous incurable serious disease: ‘Remarkable’ NY Post —
- Experimental hepatitis B drug might offer 'functional cure' for a subset of patients The Independent —
- FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results The Independent —
- A timeline of key events in the case of Kenneth Law, accused of aiding suicides CTV News —